Risk of death during the 2020 UK COVID-19 epidemic among people with rare autoimmune diseases compared to the general population. Preliminary results from the RECORDER project
Emily Peach, Megan Rutter, Peter Lanyon, Matthew J Grainge, Richard Hubbard, Jeanette Aston, Mary Bythell, Sarah Stevens, Fiona Pearce
doi: https://doi.org/10.1101/2020.10.09.20210237
Emily Peach
1Research Fellow, Division of Epidemiology and Public Health, University of Nottingham UK
Megan Rutter
2Clinical Research Fellow, Division of Epidemiology and Public Health, University of Nottingham UK
Peter Lanyon
3Consultant Rheumatologist and Honorary Clinical Associate Professor, Nottingham University Hospitals NHS Trust, Nottingham, UK
Matthew J Grainge
4Associate Professor in Medical Statistics, Division of Epidemiology and Public Health, University of Nottingham UK
Richard Hubbard
5Professor of Epidemiology and Honorary Respiratory Consultant, Division of Epidemiology and Public Health, University of Nottingham UK
Jeanette Aston
6NCARDRS rare disease data liaison, National Disease Registration Service, Public Health England
Mary Bythell
7NCARDRS Head of Rare Disease, National Disease Registration Service, Public Health England
Sarah Stevens
8Interim Deputy Director, National Disease Registration Service, Public Health England
Fiona Pearce
9Clinical Associate Professor of Rheumatology Epidemiology, Division of Epidemiology and Public Health, University of Nottingham UK
Data Availability
NCARDRS data are available to all who have a legal basis to access them. Further information is available at by application to Public Health England Office for data release (Available from www.gov.uk/government/publications/accessing-public-health-england-data/about-the-phe-odr-and-accessing-data [cited 2020 Oct 9])
Posted October 11, 2020.
Risk of death during the 2020 UK COVID-19 epidemic among people with rare autoimmune diseases compared to the general population. Preliminary results from the RECORDER project
Emily Peach, Megan Rutter, Peter Lanyon, Matthew J Grainge, Richard Hubbard, Jeanette Aston, Mary Bythell, Sarah Stevens, Fiona Pearce
medRxiv 2020.10.09.20210237; doi: https://doi.org/10.1101/2020.10.09.20210237
Risk of death during the 2020 UK COVID-19 epidemic among people with rare autoimmune diseases compared to the general population. Preliminary results from the RECORDER project
Emily Peach, Megan Rutter, Peter Lanyon, Matthew J Grainge, Richard Hubbard, Jeanette Aston, Mary Bythell, Sarah Stevens, Fiona Pearce
medRxiv 2020.10.09.20210237; doi: https://doi.org/10.1101/2020.10.09.20210237
Subject Area
Subject Areas
- Addiction Medicine (382)
- Allergy and Immunology (699)
- Anesthesia (190)
- Cardiovascular Medicine (2838)
- Dermatology (243)
- Emergency Medicine (427)
- Epidemiology (12545)
- Forensic Medicine (10)
- Gastroenterology (801)
- Genetic and Genomic Medicine (4419)
- Geriatric Medicine (401)
- Health Economics (712)
- Health Informatics (2845)
- Health Policy (1046)
- Hematology (373)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (461)
- Neurology (4173)
- Nursing (221)
- Nutrition (615)
- Oncology (2199)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (317)
- Pain Medicine (266)
- Palliative Medicine (81)
- Pathology (485)
- Pediatrics (1171)
- Primary Care Research (482)
- Public and Global Health (6766)
- Radiology and Imaging (1487)
- Respiratory Medicine (898)
- Rheumatology (430)
- Sports Medicine (368)
- Surgery (473)
- Toxicology (57)
- Transplantation (200)
- Urology (173)